26 studies found for:    tanezumab
Show Display Options
Rank Status Study
1 Completed A Study of Tanezumab in Adults With Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Tanezumab 20 mg IV;   Drug: Placebo for naproxen;   Biological: Tanezumab 10 mg IV;   Biological: Tanezumab 5 mg IV;   Biological: Placebo for tanezumab;   Drug: Naproxen
2 Terminated Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
Conditions: Osteoarthritis;   Arthritis
Interventions: Drug: NSAID;   Biological: tanezumab
3 Terminated Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study
Conditions: Osteoarthritis;   Arthritis;   Pain
Interventions: Biological: Placebo IV;   Biological: Placebo SC;   Biological: Tanezumab SC;   Biological: Tanezumab IV
4 Completed Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected
Conditions: Osteoarthritis Pain;   Chronic Low Back Pain;   Pain Due to Interstitial Cystitis
Interventions: Other: placebo;   Biological: tanezumab
5 Terminated Extension Study Of Tanezumab In Osteoarthritis
Condition: Osteoarthritis
Intervention: Biological: tanezumab
6 Terminated A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Biological: Tanezumab;   Biological: placebo
7 Terminated Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
Condition: Osteoarthritis
Interventions: Biological: tanezumab;   Drug: diclofenac;   Other: IV placebo
8 Completed Tanezumab in Osteoarthritis Of The Hip
Conditions: Arthritis;   Osteoarthritis;   Osteoarthritis, Hip
Interventions: Biological: tanezumab;   Biological: Placebo
9 Terminated Long Term Safety Study of Tanezumab in Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Biological: Tanezumab 20 mg;   Biological: Tanezumab 10 mg
10 Terminated Tanezumab and Nerve Function In Arthritis Patients
Condition: Osteoarthritis
Interventions: Biological: tanezumab;   Other: Placebo
11 Terminated Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis
Condition: Chronic Pancreatitis
Interventions: Biological: Tanezumab;   Other: Placebo
12 Terminated Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Condition: Osteoarthritis
Intervention: Biological: Tanezumab
13 Terminated A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections
Conditions: Osteoarthritis, Knee;   Osteoarthritis, Hip
Interventions: Biological: Tanezumab 2.5 mg;   Biological: Tanezumab 5 mg;   Biological: Tanezumab 10 mg
14 Completed A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
Conditions: Neoplasm Metastasis;   Palliative Care
Interventions: Drug: Tanezumab 10 mg IV;   Drug: IV Placebo for tanezumab
15 Terminated A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
Condition: Endometriosis
Interventions: Biological: Tanezumab;   Drug: Placebo
16 Completed Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously
Condition: Healthy Volunteers
Intervention: Biological: tanezumab
17 Terminated A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome
Condition: Cystitis, Interstitial
Interventions: Biological: Tanezumab;   Other: Placebo
18 Completed Tanezumab in Osteoarthritis of the Knee
Conditions: Arthritis;   Osteoarthritis
Interventions: Biological: tanezumab;   Biological: Placebo
19 Terminated Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients
Condition: Osteoarthritis
Interventions: Biological: Tanezumab;   Other: Placebo
20 Completed Tanezumab In Osteoarthritis Of The Knee (2)
Conditions: Arthritis;   Osteoarthritis
Interventions: Biological: tanezumab 10 mg;   Biological: tanezumab 5 mg;   Drug: naproxen;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results
Indicates status has not been verified in more than two years